Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

During the Trading Day
10.51 -0.24 / -2.23%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
10.69 +0.1843 / +1.75%
Volume: 300.00
Health Technology
Medical Specialties

Company Description

Avadel Pharmaceuticals Plc develops and manufactures pharmaceutical products. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

Contact Information

Avadel Pharmaceuticals Plc
Blanchardstown Corporate Park
Dublin Dublin 15
P:(347) 278-3434
Investor Relations:



Other institutional51.34%
Mutual fund holders18.11%
Individual stakeholders--

Top Executives

Michael Shannon AndersonPresident, Chief Executive Officer & Director
Michael F. KananCFO, Treasurer, Director & CAO
David MonteithVice President-Research & Development
Gregory J. DivisChief Commercial Officer & Executive VP
Phillandas T. ThompsonSecretary, Director, SVP & General Counsel